Search
Showing results 1 - 4 of 4

It’s important to understand opportunity cost when assessing whether a project is worth doing.

Meet Kimberly Yeung, Principal, Strategic Investments and Women in Technology Venture Fund.

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi).

I wanted to be in an ownership position rather than just manage the company. BDC had confidence in us and came through with the financing we needed. It was a seamless and effortless experience!